Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

Innovative supportive care model tackles burdensome symptoms, challenges of dementia

Individuals with dementia often experience burdensome symptoms such as agitation, aggression, anxiety and pain, but have difficulty with comprehension and communication, making it challenging for healthcare providers to provide appropriate treatment.

26 Oct 2018

Air pollution on the rise outside GP offices and hospitals finds study

A new report has shown that the air outside the offices of General Practitioners and outside hospitals are high in pollutants. This can aggravate the lung problems in patients of asthma and Chronic Obstructive Pulmonary Disease (COPD) says the report.

26 Oct 2018

Treating gum disease could help people with Type 2 diabetes manage their blood glucose levels

A study funded by Diabetes UK has found that treating periodontitis (gum disease) could help people with Type 2 diabetes manage their blood glucose levels, and may reduce their risk of diabetes-related complications.

25 Oct 2018

Study explores whether wearable patches could help patients to monitor blood pressure

Because only half of the people in the United States diagnosed with high blood pressure have their condition under control, an easy, cost-effective method to monitor blood pressure would be a significant advance to reduce the risk of heart disease and stroke.

25 Oct 2018

Bioengineering scientists propose new paradigm for research into cardiovascular diseases

Thrombosis-on-a-chip, vasculature-on-a-chip and engineered models of human cardiac fibrosis are just a few of the new technologies revolutionizing research into human cardiovascular disease--a condition responsible for 17 million deaths per annum globally.

25 Oct 2018

ConnectToBrain project seeks to improve techniques for brain stimulation in current clinical use

The costs associated with neurological diseases amount to 1000 billion euros per year in Europe alone.

23 Oct 2018

Interweaving anxiety disorder associated with stuttering remains unrecognized

While stuttering impacts the lives of approximately 1-2 percent of adults and around 4-5 percent of children, the mental health impact of this disorder largely remains unrecognized.

23 Oct 2018

People with periodontal disease less likely to reach healthy blood pressure ranges

People with high blood pressure taking medication for their condition are more likely to benefit from the therapy if they have good oral health, according to new research in the American Heart Association's journal Hypertension.

22 Oct 2018

11th World Stroke Congress examines high stroke impact in low- and middle-income countries

11th World Stroke Congress brings together leading international stroke experts and an unparalleled scientific program covering epidemiology, prevention, acute care, recovery and rehabilitation in 100s of sessions and oral posters.

22 Oct 2018

Deaths related to air pollution in the U.S. decreased by 47% between 1990 and 2010

Air pollution in the U.S. has decreased since about 1990, and a new study conducted at the University of North Carolina at Chapel Hill now shows that this air quality improvement has brought substantial public health benefits.

20 Oct 2018

ApoE4 gene linked with chronic inflammation increases risk for Alzheimer's disease

While it is widely shown that possessing the ApoE4 gene is the major genetic risk factor of Alzheimer's disease, not all ApoE4 carriers develop AD.

20 Oct 2018

Incidence of stroke has risen steadily among marijuana users, show studies

11th World Stroke Congress brings together leading international stroke experts and an unparalleled scientific program covering epidemiology, prevention, acute care, rehabilitation and recovery in 100s of sessions and oral posters.

19 Oct 2018

URMC researchers discover new approach to deliver therapeutics to the brain

Researchers at the University of Rochester Medical Center have discovered a potentially new approach to deliver therapeutics more effectively to the brain. The research could have implications for the treatment of a wide range of diseases, including Alzheimer's, Parkinson's, ALS, and brain cancer.

19 Oct 2018

The immune system also plays a key role in day-to-day function of healthy organs

The cells of the immune system sustain life by infiltrating infected and dmaged tissue and eliminating pathogenic microorganisms and cell debris.

19 Oct 2018

Scripps researchers successfully test potential new smoking-cessation treatment in rodents

Scientists at Scripps Research have successfully tested a potential new smoking-cessation treatment in rodents.

19 Oct 2018

Research aims to address health disparities in African-American men

The burden of risk factors for chronic disease is substantially higher in black men compared with their white counterparts, including a higher prevalence of obesity and hypertension.

17 Oct 2018

Purdue Pharma, Eisai announce positive topline results from Phase 3 study of lemborexant

Eisai Co., Ltd. and Purdue Pharma L.P. announced positive topline results from SUNRISE 2, a long-term Phase 3 efficacy and safety evaluation of lemborexant, an investigational agent for sleep-wake regulation currently being studied for the potential treatment of multiple sleep-wake disorders.

17 Oct 2018

New research identifies modifiable dementia risk factor in elderly people

For older adults, it may seem as though the die is already cast regarding their odds of developing dementia, but new research from the University of Pittsburgh has identified a dementia risk factor among older adults that should be modifiable even well into old age.

16 Oct 2018

Eisai enters into agreement with Eurofarma for development and sales of lorcaserin in 17 countries

Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride (generic name, product name in the United States: BELVIQ, product name for once-daily formulation in the United States: BELVIQ XR, "lorcaserin") in 17 countries in Latin America and the Caribbean, excluding Brazil, to Eurofarma Laboratorios S.A. which has a business foundation in Latin America.

16 Oct 2018

Study: Only 59% of young adults undergoing surgery are fluid responsive

Cheetah Medical, a Massachusetts-based leader in non-invasive fluid management devices, today announced study results leveraging Cheetah Medical technology were presented at the American Society of Anesthesiologists ANESTHESIOLOGY 2018 annual meeting in San Francisco, held from October 13-17.

16 Oct 2018

Stroke News and Research

Further Reading

Innovative supportive care model tackles burdensome symptoms, challenges of dementia

Air pollution on the rise outside GP offices and hospitals finds study

Treating gum disease could help people with Type 2 diabetes manage their blood glucose levels

Study explores whether wearable patches could help patients to monitor blood pressure

Bioengineering scientists propose new paradigm for research into cardiovascular diseases

ConnectToBrain project seeks to improve techniques for brain stimulation in current clinical use

Interweaving anxiety disorder associated with stuttering remains unrecognized

People with periodontal disease less likely to reach healthy blood pressure ranges

11th World Stroke Congress examines high stroke impact in low- and middle-income countries

Deaths related to air pollution in the U.S. decreased by 47% between 1990 and 2010

ApoE4 gene linked with chronic inflammation increases risk for Alzheimer's disease

Incidence of stroke has risen steadily among marijuana users, show studies

URMC researchers discover new approach to deliver therapeutics to the brain

The immune system also plays a key role in day-to-day function of healthy organs

Scripps researchers successfully test potential new smoking-cessation treatment in rodents

Research aims to address health disparities in African-American men

Purdue Pharma, Eisai announce positive topline results from Phase 3 study of lemborexant

New research identifies modifiable dementia risk factor in elderly people

Eisai enters into agreement with Eurofarma for development and sales of lorcaserin in 17 countries

Study: Only 59% of young adults undergoing surgery are fluid responsive

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News